🇺🇸 Cytokinetics, Incorporated
Forum topic · CYTK · Company page: financials, ownership and filings
Join the discussion on Cytokinetics, Incorporated
Loading…
Results announced on 4 November 2026
Cytokinetics, Incorporated announced results on 4 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $48 million (up 2352% from a year earlier) and a net loss of $190 million.
Insider trading in October 2026
Directors and officers of Cytokinetics, Incorporated reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $910,465 in 3 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 443 funds hold $6.3 billion
443 mutual funds in 2 countries hold shares of Cytokinetics, Incorporated worth $6.3 billion, about 54.9% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 302 funds added shares and 121 sold; on balance they bought $454 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.